Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of VPA Concentration on Photoparoxysmal Response
NCT00609245Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of valproic acid in photosensitive epilepsy (PSE), sponsored by Vanderbilt University Medical Center. Primary endpoint: Standard Photosensitive Range at 12 hours. Started Dec 2007; status: completed.
02
Drugs
valproic acid
03
Conditions
photosensitive epilepsy (PSE)
Beyond the preview
Go deeper on NCT00609245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609245.